eribulin plus gemcitabine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for eribulin plus gemcitabine, covering 2020-07-14 to 2020-07-14. Get the full timeline:
Most recent: Clinical Trial Update: Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast Cancer [Phase 2]